Placement Success: William Senapedis joins Dewpoint Therapeutics

Congratulations to William Senapedis, who joins Dewpoint Therapeutics today as Head of Late Discovery & Translational.

William steps into this role as Dewpoint advances its pipeline of condensate-modulating therapies, a novel class of medicines aimed at diseases long considered undruggable. Their goal is to continue to bridge early discovery and translational science to move promising condensate modulators toward the clinic with rigor and speed.

We're proud to have partnered with Dewpoint on this search and to welcome William to a company redefining what's possible in drug discovery.